A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients

BACKGROUND: Currently, the main goal of cancer research is to increase longevity of patients suffering malignant cancers. The promising results of BCc1 in vitro and vivo experiments made us look into the effect of BCc1 nanomedicine on patients with cancer in a clinical trial. METHODS: The present in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Nanobiotechnology
Hauptverfasser: Hafizi, Maryam, Kalanaky, Somayeh, moaiery, Hassan, Khayamzadeh, Maryam, Noorian, Sajad, Kaveh, Vahid, Gharib, Behrooz, Foudazi, Hossein, Razavi, Mohsen, Jenabian, Arash, Salimi, Saeid, Sereshki, Mohammad Mahdi Adib, Mirzaei, Hamid Reza, Zarghi, Afshin, Fakharzadeh, Saideh, Nazaran, Mohammad Hassan, Akbari, Mohammad Esmaeil
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6458717/
https://ncbi.nlm.nih.gov/pubmed/30971278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-019-0484-0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge